PKG drug G1

CAS : 374703-78-3

Ref. 3D-ZPA70378

Informations sur le produit

• Nom: PKG drug G1
• Marque: Biosynth
• Description: PKG drug G1 is a synthetic small-molecule inhibitor, which is a laboratory-engineered compound designed to interfere with the signaling pathways involved in cell cycle regulation. It is specifically sourced through chemical synthesis, allowing for precise modifications to enhance its stability and efficacy in cellular systems. The mode of action of PKG drug G1 involves selectively targeting and inhibiting certain protein kinases that play a crucial role in the progression of the cell cycle, particularly the G1 phase. By inhibiting these kinases, the drug effectively halts cell division, making it a potential candidate for research in cancer treatment.

Propriétés chimiques

• Masse moléculaire: 257.31 g/mol
• Formule: C₁₃H₁₁N₃OS
• Degré de pureté: Min. 95%